Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-26 Sale |
2023-01-30 4:05 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
37,254 | $45.08 | $1,679,510 | 438,559 (Direct) |
View |
2023-01-23 Sale |
2023-01-25 5:25 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
20,236 | $45.02 | $910,947 | 491,725 (Direct) |
View |
2023-01-18 Sale |
2023-01-20 4:18 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
47,195 | $45.14 | $2,130,382 | 274,332 (Direct) |
View |
2023-01-03 Sale |
2023-01-05 4:06 pm |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
53,729 | $37.46 | $2,012,490 | 246,867 (Direct) |
View |
2022-12-12 Sale |
2022-12-14 9:50 pm |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
51,015 | $42.7 | $2,178,229 | 285,279 (Direct) |
View |
2022-10-31 Sale |
2022-11-02 4:30 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $46.33 | $2,316,428 | 1,161,520 (Indirect Direct) |
View |
2022-09-06 Sale |
2022-09-08 11:04 am |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
551 | $54.25 | $29,892 | 4,964,709 (Indirect) |
View |
2022-08-05 Sale |
2022-08-08 4:49 pm |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
20,326 | $60.5 | $1,229,807 | 2,231,506 (Indirect) |
View |
2022-07-28 Sale |
2022-07-29 4:06 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $65.76 | $3,288,081 | 1,211,520 (Indirect Direct) |
View |
2022-04-28 Sale |
2022-05-02 6:51 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $37.98 | $1,898,899 | 1,709,415 (Indirect Direct) |
View |
2022-04-13 Sale |
2022-04-14 5:13 pm |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
19,466 | $50.41 | $981,205 | 2,701,029 (Indirect) |
View |
2022-03-31 Sale |
2022-04-04 8:32 pm |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
1,859 | $59.11 | $109,885 | 115,614 (Direct) |
View |
2022-03-31 Sale |
2022-04-04 8:27 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
6,261 | $59.11 | $370,088 | 1,252,070 (Indirect Direct) |
View |
2022-03-31 Sale |
2022-04-04 8:22 pm |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
1,787 | $59.11 | $105,630 | 38,278 (Direct) |
View |
2022-01-31 Sale(A) |
2022-02-02 6:00 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
50,000 | $66.84 | $3,341,903 | 2,963,840 (Indirect Direct) |
View |
2021-12-22 Sale |
2021-12-23 6:00 pm |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
2,607 | $86.13 | $224,531 | 152,419 (Direct) |
View |
2021-12-20 Sale |
2021-12-22 6:00 pm |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
29,393 | $85.62 | $2,516,672 | 272,383 (Direct) |
View |
2021-10-06 Sale |
2021-10-08 4:21 pm |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
47,700 | $83.8 | $3,997,268 | 1,548,170 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-03-30 Exercise |
2023-03-31 7:51 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer |
8,941 | $7.22 | 115,292 (Direct) |
View |
2023-03-31 Option Award |
2023-03-31 7:51 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer |
17,500 | $0 | 115,292 (Direct) |
View |
2023-03-30 Exercise |
2023-03-31 7:51 pm |
N/A 2029-05-16 |
Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer |
8,941 | $0 | 115,292 (Direct) |
View |
2023-01-31 Option Award |
2023-03-31 7:49 pm |
N/A 2033-01-31 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
60,000 | $0 | 155,962 (Direct) |
View |
2023-03-31 Exercise |
2023-03-31 7:48 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
13,850 | $7.22 | 1,541,557 (Direct) |
View |
2023-01-31 Option Award |
2023-03-31 7:48 pm |
N/A 2033-01-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
168,750 | $0 | 1,541,557 (Direct) |
View |
2023-03-31 Exercise |
2023-03-31 7:48 pm |
N/A 2029-05-17 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
13,850 | $0 | 1,541,557 (Direct) |
View |
2023-03-06 Acquisition |
2023-03-31 7:48 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
225 | $0 | 1,541,557 (Direct) |
View |
2023-03-31 Option Award |
2023-03-31 7:47 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer |
20,000 | $0 | 85,129 (Direct) |
View |
2023-01-31 Option Award |
2023-03-31 7:46 pm |
N/A 2033-01-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
40,000 | $0 | 71,277 (Direct) |
View |
Ownership |
2023-03-27 6:23 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Simon Amy Chief Medical Officer |
0 | $0 | 224,629 (Direct) |
View |
Ownership |
2023-03-27 6:22 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Bellon Christine Chief Legal Officer |
0 | $0 | 221,751 (Direct) |
View |
2023-01-26 Exercise |
2023-01-30 4:05 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
37,254 | $0 | 438,559 (Direct) |
View |
2023-01-26 Exercise |
2023-01-30 4:05 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
37,254 | $13.68 | 438,559 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 5:25 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
20,236 | $0 | 491,725 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 5:25 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
20,236 | $13.68 | 491,725 (Direct) |
View |
2023-01-18 Exercise |
2023-01-20 4:18 pm |
N/A 2029-08-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
39,886 | $0 | 274,332 (Direct) |
View |
2023-01-18 Exercise |
2023-01-20 4:18 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann Chief Financial Officer |
39,886 | $13.68 | 274,332 (Direct) |
View |
2023-01-03 Exercise |
2023-01-05 4:06 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
49,403 | $0.67 | 246,867 (Direct) |
View |
2023-01-03 Exercise |
2023-01-05 4:06 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
53,729 | $0 | 246,867 (Direct) |
View |
2023-01-03 Exercise |
2023-01-05 4:06 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
4,326 | $4.22 | 246,867 (Direct) |
View |
2022-12-30 Exercise |
2023-01-03 4:31 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
4,500 | $0.67 | 287,164 (Direct) |
View |
2022-12-30 Exercise |
2023-01-03 4:31 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
4,500 | $0 | 287,164 (Direct) |
View |
2022-12-12 Exercise(A) |
2022-12-20 4:05 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
18,211 | $0 | 9,106 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 9:50 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
18,211 | $0.67 | 285,279 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 9:50 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
26,863 | $0 | 285,279 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 9:50 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
8,652 | $4.22 | 285,279 (Direct) |
View |
2022-09-06 Other |
2022-09-08 11:04 am |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
26,171 | $0 | 4,964,709 (Indirect) |
View |
2022-09-01 Option Award |
2022-09-02 4:06 pm |
N/A 2032-09-01 |
Beam Therapeutics Inc. | BEAM | Burow Kristina Director |
10,391 | $0 | 10,391 (Direct) |
View |
2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A 2032-09-01 |
Beam Therapeutics Inc. | BEAM | Ho Carole Director |
10,391 | $0 | 10,391 (Direct) |
View |
2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A 2032-09-01 |
Beam Therapeutics Inc. | BEAM | MARAGANORE JOHN Director |
10,391 | $0 | 10,391 (Direct) |
View |
2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A 2032-09-01 |
Beam Therapeutics Inc. | BEAM | COOPER GRAHAM K Director |
10,391 | $0 | 10,391 (Direct) |
View |
2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A 2032-09-01 |
Beam Therapeutics Inc. | BEAM | Walsh Kathleen E Director |
10,391 | $0 | 10,391 (Direct) |
View |
2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A 2032-09-01 |
Beam Therapeutics Inc. | BEAM | Fishman Mark Director |
10,391 | $0 | 10,391 (Direct) |
View |
2022-08-04 Other |
2022-08-08 4:49 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
2,231,506 | $0 | 2,231,506 (Indirect) |
View |
2022-04-28 Exercise |
2022-05-02 6:51 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,246 | $7.22 | 1,709,415 (Direct) |
View |
2022-04-28 Exercise |
2022-05-02 6:51 pm |
N/A 2029-05-17 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
59,450 | $0 | 1,709,415 (Direct) |
View |
2022-04-28 Exercise |
2022-05-02 6:51 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
47,204 | $1.03 | 1,709,415 (Direct) |
View |
2022-04-12 Other |
2022-04-14 5:13 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
2,701,029 | $0 | 2,701,029 (Indirect) |
View |
2022-03-31 Option Award |
2022-04-04 8:32 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
15,000 | $0 | 115,614 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 8:27 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
56,250 | $0 | 1,252,070 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 8:22 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
15,000 | $0 | 38,278 (Direct) |
View |
2022-01-31 Option Award |
2022-02-02 6:00 pm |
N/A 2032-01-31 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
30,000 | $0 | 30,000 (Direct) |
View |
2022-01-31 Option Award(A) |
2022-02-02 6:00 pm |
N/A 2032-01-31 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
112,500 | $0 | 2,963,840 (Direct) |
View |
2022-01-31 Exercise(A) |
2022-02-02 6:00 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
100,000 | $0 | 2,963,840 (Direct) |
View |
2022-01-31 Exercise(A) |
2022-02-02 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
100,000 | $1.03 | 2,963,840 (Direct) |
View |
2021-11-16 Gift(A) |
2022-02-02 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
12,000 | $0 | 2,963,840 (Direct) |
View |
2022-01-31 Option Award |
2022-02-02 6:00 pm |
N/A 2032-01-31 |
Beam Therapeutics Inc. | BEAM | Burrell Terry-Ann CFO |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2022-01-24 08:53 am |
N/A N/A |
Beam Therapeutics Inc. | BEAM | FMR LLC See Remark 1 10% Owner |
0 | $0 | 5,989,617 (Indirect) |
View |
2021-12-29 Exercise |
2021-12-30 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
39,700 | $0.67 | 310,175 (Direct) |
View |
2021-12-29 Exercise |
2021-12-30 6:00 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
39,700 | $0 | 310,175 (Direct) |
View |
2021-12-22 Exercise |
2021-12-23 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
2,607 | $7.22 | 152,419 (Direct) |
View |
2021-12-22 Exercise |
2021-12-23 6:00 pm |
N/A 2029-05-17 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
2,607 | $0 | 152,419 (Direct) |
View |
2021-12-20 Exercise |
2021-12-22 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
29,393 | $7.22 | 272,383 (Direct) |
View |
2021-12-20 Exercise |
2021-12-22 6:00 pm |
N/A 2029-05-17 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
29,393 | $0 | 272,383 (Direct) |
View |
2021-11-05 Option Award |
2021-11-08 8:05 pm |
N/A 2031-11-05 |
Beam Therapeutics Inc. | BEAM | MARAGANORE JOHN Director |
13,133 | $0 | 13,133 (Direct) |
View |
2021-10-06 Exercise |
2021-10-08 4:21 pm |
N/A 2028-07-13 |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
27,700 | $0 | 1,548,170 (Direct) |
View |
2021-10-06 Exercise |
2021-10-08 4:21 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Evans John M. CEO |
27,700 | $1.03 | 1,548,170 (Direct) |
View |
2021-09-17 Exercise |
2021-09-21 6:00 pm |
N/A N/A |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
18,012 | $0.67 | 310,175 (Direct) |
View |
2021-09-17 Exercise |
2021-09-21 6:00 pm |
N/A 2028-05-08 |
Beam Therapeutics Inc. | BEAM | Ciaramella Giuseppe President & CSO |
18,012 | $0 | 310,175 (Direct) |
View |